However, our collective analyses in EOC cell line models and tumors has indicated that tumor cells with high baseline levels of SAT RNAs lack IFN pathway activation, implying that they have developed an adaptation to suppress the IFN response to repeats. The gene discussed is IFNA1; the disease is neoplasm.